Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neurogenic Orthostatic Hypotension”

47 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 47 results

Post-approval studies (Phase 4)Study completedNCT03350659
What this trial is testing

Efficacy and Safety of Midodrine and Atomoxetine for Neurogenic OH

Who this might be right for
Neurogenic Orthostatic Hypotension
Seoul National University Hospital 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT07089043
What this trial is testing

A Study in Subjects With Neurogenic Orthostatic Hypotension

Who this might be right for
Neurogenic Orthostatic Hypotension
CuraSen Therapeutics, Inc. 12
Large-scale testing (Phase 3)Study completedNCT01176240
What this trial is testing

A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease

Who this might be right for
Orthostatic HypotensionParkinson's Disease
Chelsea Therapeutics 225
Large-scale testing (Phase 3)Active Not RecruitingNCT05696717
What this trial is testing

Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy

Who this might be right for
Symptomatic Neurogenic Orthostatic HypotensionMSA - Multiple System Atrophy
Theravance Biopharma 102
Testing effectiveness (Phase 2)UnknownNCT00758849
What this trial is testing

Fipamezole in Neurogenic Orthostatic Hypotension

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension (NOH)Parkinson's DiseaseMultiple System Atrophy
Juvantia Pharma Ltd 24
Not applicableStudy completedNCT01223391
What this trial is testing

Abdominal Compression in Orthostatic Hypotension

Who this might be right for
Autonomic FailureOrthostatic Hypotension
Mayo Clinic 13
Post-approval studies (Phase 4)UnknownNCT04128137
What this trial is testing

Efficacy and Tolerance of Flucortac in Patients With Orthostatic Neurogenic Hypotension

Who this might be right for
Neurogenic Orthostatic Hypotension
H.A.C. PHARMA 90
Early research (Phase 1)Study completedNCT01149629
What this trial is testing

Study of the Fed-Fast Pharmocokinetics and Bioequivalance of 300mg Capsules of Droxidopa

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension
Chelsea Therapeutics 24
Large-scale testing (Phase 3)Study completedNCT00633880
What this trial is testing

Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension (NOH)Non-diabetic NeuropathyPrimary Autonomic Failure+1 more
Chelsea Therapeutics 181
Very early researchEnded earlyNCT02963181
What this trial is testing

Effects of Melatonin to Reduce Nocturnal Hypertension in Patients With Neurogenic Orthostatic Hypotension

Who this might be right for
Hypotension, OrthostaticHypertensionAutonomic Nervous System Diseases
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 10
Large-scale testing (Phase 3)Ended earlyNCT04095793
What this trial is testing

Phase 3 Open-Label Extension Study of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension
Theravance Biopharma 110
Not applicableNot Yet RecruitingNCT07706829
What this trial is testing

Artificial Intelligence-based Parkinson's Disease Risk Assessment (AI-PRA) Study

Who this might be right for
Parkinson Disease (PD)REM Sleep Behavior Disorder (iRBD)Neurogenic Orthostatic Hypotension+1 more
Queen Mary University of London 60
Post-approval studies (Phase 4)Study completedNCT00046475
What this trial is testing

Patients With Neurogenic Orthostatic Hypotension

Who this might be right for
Hypotension, Orthostatic
Shire 140
Very early researchStudy completedNCT04620382
What this trial is testing

Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients

Who this might be right for
Neurogenic Orthostatic HypotensionAutonomic FailurePure Autonomic Failure+2 more
Vanderbilt University Medical Center 31
Large-scale testing (Phase 3)Ended earlyNCT03829657
What this trial is testing

Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure

Who this might be right for
Symptomatic Neurogenic Orthostatic HypotensionMSAParkinson's Disease (PD)+1 more
Theravance Biopharma 203
Post-approval studies (Phase 4)Study completedNCT02586623
What this trial is testing

Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension
H. Lundbeck A/S 453
Large-scale testing (Phase 3)Study completedNCT00738062
What this trial is testing

Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)

Who this might be right for
Neurogenic Orthostatic HypotensionNon-Diabetic Autonomic NeuropathyMultiple System Atrophy+1 more
Chelsea Therapeutics 103
Testing effectiveness (Phase 2)Ended earlyNCT00977171
What this trial is testing

Study To Assess The Clinical Benefit Of Droxidopa In Subjects With Chronic Fatigue Syndrome

Who this might be right for
Chronic Fatigue SyndromeOrthostatic HypotensionNeurally Mediated Hypotension+1 more
Chelsea Therapeutics 3
Testing effectiveness (Phase 2)Study completedNCT01971008
What this trial is testing

Abdominal Binder to Treat Orthostatic Hypotension (OH) in Parkinson's Disease (PD)

Who this might be right for
Parkinson's DiseaseNeurogenic Orthostatic Hypotension in Parkinson's Disease
Medical University Innsbruck 15
Testing effectiveness (Phase 2)Study completedNCT02784535
What this trial is testing

Norepinephrine Transporter Blockade, Autonomic Failure (NETAF)

Who this might be right for
Neurogenic Orthostatic Hypotension
Vanderbilt University Medical Center 48
Next Page